Skip to Main Content

Paper Details

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Nat Genet
1176
2015
AXIN1, CCND1, CDKN2A, CTNNB1, FGF19, FGF3, FGF4, HBV, HCC, TERT promoter, TP53, aflatoxin B1, alcohol, altered genes, hepatitis B virus, hepatocellular, hepatocellular carcinoma, hepatocellular carcinomas, liver tumors, patients, putative driver genes, tumor, tumors
Author NameAffiliation
Ludmil B AlexandrovWellcome Trust Sanger Institute
Ludmil B AlexandrovLos Alamos National Laboratory
Ludmil B AlexandrovWellcome Trust Sanger Institute
Ludmil B AlexandrovLos Alamos National Laboratory
Fabien CalvoInserm, Institut Universitaire d'Hematologie
Fabien CalvoUniversite Paris Descartes
Fabien CalvoUniversite Paris 13
Fabien CalvoUniversite Paris Diderot
Michael R StrattonWellcome Trust Sanger Institute
  • 1 - 9

Datasets

Release 1.2